In a regulatory filing, Enanta (ENTA) disclosed that its CEO Jay Luly bought 45K shares of common stock on February 12th in a total transaction size of $256K.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENTA:
- Enanta Pharmaceuticals: Buy Rating Driven by Promising RSV Developments and Strategic Plans
- Enanta reports Q1 EPS ($1.05), consensus ($1.35)
- Enanta Pharmaceuticals (ENTA) Q1 Earnings Cheat Sheet
- Enanta to appeal ruling related to ‘953 patent infringement lawsuit
- Enanta price target lowered to $18 from $27 at H.C. Wainwright